Literature DB >> 29382232

What are the main predictors of in-hospital mortality in patients with infective endocarditis: a review.

Wilhelm P Mistiaen1,2.   

Abstract

OBJECTIVES: Infective endocarditis (IE) has a high 30-day mortality. Surgery is needed in many patients. The preoperative hemodynamic status (congestive heart failure, need for urgent/emergent surgery or mechanical support, NYHA class III/IV) could have an impact on postoperative outcome. Each of these parameters is an indication for the inadequacy of the left ventricle to maintain an adequate circulation Methods. A literature search was performed using "endocarditis AND hospital mortality OR outcome AND predictor" and "International Collaboration on Endocarditis - Prospective Cohort Study" in Web of Science database, from 2010-2017. The focus was hospital mortality and its predictors. Manuscripts were excluded if no logistic regression or propensity analysis was available. The predictors were ranked according the odds ratios. Articles with risk scores based on multivariate analysis were also added.
RESULTS: Most studies are coming from one tertiary center and are retrospective, with different designs. Recruitment periods are long and sample sizes small. Definitions of preoperative events such as hemodynamic status are not uniform. Thirty-day mortality varies between 10 and 50%. In 8 of 18 papers where the hemodynamic status is included, it is ranked as first and in 3 as second. The scoring systems confirm in several occasions the importance of left ventricular factors. DISCUSSION: The heterogeneity of the included papers and lack of uniform definitions of preoperative events precludes a proper meta-analysis. Nevertheless, heart failure and a compromised hemodynamic status can be identified as the dominant predictor for 30-day mortality of IE. This seems avoidable by early surgery.

Entities:  

Keywords:  Infective endocarditis; hemodynamic status; hospital mortality

Mesh:

Year:  2018        PMID: 29382232     DOI: 10.1080/14017431.2018.1433318

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  4 in total

1.  Self-assessed health status and associated mortality in endocarditis: secondary findings from the POET trial.

Authors:  Johan S Bundgaard; Kasper Iversen; Mia Pries-Heje; Nikolaj Ihlemann; Sabine U Gill; Trine Madsen; Hanne Elming; Jonas A Povlsen; Niels E Bruun; Dan E Høfsten; Kurt Fuursted; Jens J Christensen; Martin Schultz; Flemming Rosenvinge; Jannik Helweg-Larsen; Lars Køber; Christian Torp-Pedersen; Emil L Fosbøl; Niels Tønder; Claus Moser; Henning Bundgaard; Ulrik M Mogensen
Journal:  Qual Life Res       Date:  2022-03-29       Impact factor: 3.440

2.  Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device-Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017.

Authors:  Pegah Khaloo; Uwajachukwumma A Uzomah; Ayman Shaqdan; Pablo A Ledesma; Jennifer Galvin; Leon M Ptaszek; Jeremy N Ruskin
Journal:  J Am Heart Assoc       Date:  2022-08-24       Impact factor: 6.106

Review 3.  Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies.

Authors:  Joop J P Kouijzer; Daniëlle J Noordermeer; Wouter J van Leeuwen; Nelianne J Verkaik; Kirby R Lattwein
Journal:  Front Cell Dev Biol       Date:  2022-10-03

4.  Infective endocarditis according to type 2 diabetes mellitus status: an observational study in Spain, 2001-2015.

Authors:  José M de Miguel-Yanes; Rodrigo Jiménez-García; Valentín Hernández-Barrera; Javier de Miguel-Díez; Manuel Méndez-Bailón; Nuria Muñoz-Rivas; Napoleón Pérez-Farinós; Ana López-de-Andrés
Journal:  Cardiovasc Diabetol       Date:  2019-11-21       Impact factor: 9.951

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.